Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Bristol Myers Squibb is seeking a senior scientist to lead the Model-Informed Drug Development (MIDD) strategy for assets in clinical development. You will drive PMx analyses and MBMA to inform dose selection, study design, and regulatory submissions.
The role requires an advanced degree and 5+ years in pharmacometrics, with expertise in R, NONMEM, Monolix, Pumas, MATLAB, Python, or Julia. Hybrid work in Cambridge area offers collaboration with cross-functional teams and external vendors.
At Bristol Myers Squibb, our employees often ask, "Who are you working for?"-a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.
Leads the development and implementation of the Model-Informed Drug Development (MIDD) strategy for drugs and other therapeutic agents in clinical development, in partnership with Clinical Pharmacology (CP) and other quantitative functions. This role places quantitative evidence at the center of development and regulatory decision-making.
MIDD advances drug development by integrating diverse data through pharmacometric (PMx) models to inform development decisions and regulatory assessments. Model-Based Meta-Analysis (MBMA) provides a quantitative assessment of competitors and comparators to further refine asset strategy. MIDD informs dose and regimen selection, clinical study hypotheses, and the overall clinical data package supporting regulatory assessment of clinical pharmacology and benefit-risk. PMx analyses may also influence regulatory approval decisions and, in some cases, serve as a primary basis for approval.
#LI-Hybrid
Cambridge Crossing: $209,250 - $253,565
The starting pay range(s) listed above is for full-time employees (FTE). You may also be eligible for additional discretionary incentive cash and stock opportunities. We determine starting pay thoughtfully - carefully considering the nature of the role, required skills, work location, schedule and the knowledge and experience you bring. Final compensation is guide